Effect of Haemophilus influenzae Type b and 13-Valent Pneumococcal Conjugate Vaccines on Childhood Pneumonia Hospitalizations and Deaths in Botswana
Author(s) -
Morgan Congdon,
Hwanhee Hong,
Rebecca Young,
Coleen K. Cunningham,
Leslie A. Enane,
Tonya ArscottMills,
Francis Msume Banda,
Mamiki Chise,
Keneilwe Motlhatlhedi,
Kristen A. Feemster,
Sweta Patel,
Sefelani Boiditswe,
Tiroyaone Leburu,
Samir S. Shah,
Andrew P. Steenhoff,
Matthew S. Kelly
Publication year - 2020
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa919
Subject(s) - medicine , pneumonia , pneumococcal conjugate vaccine , pediatrics , haemophilus influenzae , hib vaccine , pneumococcal pneumonia , vaccination , mortality rate , streptococcus pneumoniae , conjugate vaccine , immunization , immunology , antibiotics , immune system , microbiology and biotechnology , biology
Globally, pneumonia is the leading cause of death among children. Few data exist regarding the effect of Haemophilus influenzae type b (Hib) vaccine and 13-valent pneumococcal conjugate vaccine (PCV-13) on the burden of childhood pneumonia in African settings.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom